Back to dashboard
MedicaidCoverageMedium impact

Newsletter Vol. 15, No. 01

New Jersey Medicaid·NJ · Nephrology, Oncology, Hematology·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This is a provider notice regarding Epoetin Alfa (Erythropoietin/EPO) from New Jersey Medicaid. Without access to the full policy content, the specific changes to billing, coverage, or prior authorization requirements cannot be determined from the summary alone.

Action Required

Action needed
Immediately: Download and review the full policy document from https://www.njmmis.com/documentDownload.aspx?document=15-01.pdf to determine specific billing changes for Epoetin Alfa. Billing team should identify any new prior authorization requirements, coverage changes, or billing code updates that may affect claims processing.

Related policy hubs